𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical spectrum of levodopa-induced motor complications

✍ Scribed by E. Hametner; K. Seppi; W. Poewe

Book ID
106095024
Publisher
Springer
Year
2010
Tongue
English
Weight
233 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of levodopa-induced motor comp
Treatment of levodopa-induced motor complications
✍ Fabrizio Stocchi; Michele Tagliati; C. Warren Olanow 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Chronic levodopa treatment for Parkinson's disease patients is frequently associated with the development of motor complications such as end-of-dose wearing-off and dyskinesias. In this review, we provide an overview of the strategies available for dealing with these problems. Medical management inc

Glutamate release inhibition ineffective
Glutamate release inhibition ineffective in Levodopa-induced motor complications
✍ William Bara-Jimenez; Tzvetelina D. Dimitrova; Abdullah Sherzai; Murat Aksu; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

## Abstract Reported benefits of various glutamatergic receptor antagonists in Parkinson's disease (PD) prompted an evaluation of the antidyskinetic effect of a putative glutamate release inhibitor in 15 moderately advanced patients. In a 3‐week, double‐blind, proof‐of‐concept study, riluzole (200

Clinical–Pathological study of levodopa
Clinical–Pathological study of levodopa complications
✍ Azi H. Rajput; Mark E. Fenton; Sam Birdi; Rob Macaulay; David George; Bohdar Roz 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract We sought to determine the continued benefit and the pattern of motor complications of long‐term levodopa treatment in Parkinson's disease. Patients were evaluated between 1968 and 1996. Only those who had an adequate levodopa trial and in whom autopsy revealed Lewy body Parkinson's dis